Center of Regenerative Medicine in Barcelona, Dr. Aiguader, 88, 08003 Barcelona, Spain.
Cell Stem Cell. 2013 Sep 5;13(3):341-50. doi: 10.1016/j.stem.2013.06.019. Epub 2013 Jul 18.
Since the initial discovery that OCT4, SOX2, KLF4, and c-MYC overexpression sufficed for the induction of pluripotency in somatic cells, methodologies replacing the original factors have enhanced our understanding of the reprogramming process. However, unlike in mouse, OCT4 has not been replaced successfully during reprogramming of human cells. Here we report on a strategy to accomplish this replacement. Through a combination of transcriptome and bioinformatic analysis we have identified factors previously characterized as being lineage specifiers that are able to replace OCT4 and SOX2 in the reprogramming of human fibroblasts. Our results show that it is possible to replace OCT4 and SOX2 simultaneously with alternative lineage specifiers in the reprogramming of human cells. At a broader level, they also support a model in which counteracting lineage specification networks underlies the induction of pluripotency.
自最初发现 OCT4、SOX2、KLF4 和 c-MYC 的过表达足以诱导体细胞多能性以来,替代原始因子的方法提高了我们对重编程过程的理解。然而,与小鼠不同的是,在人类细胞的重编程过程中,OCT4 并没有被成功替代。在这里,我们报告了一种实现这一替代的策略。通过转录组和生物信息学分析的结合,我们已经鉴定出以前被表征为谱系特异性因子的因子,这些因子能够在人成纤维细胞的重编程中替代 OCT4 和 SOX2。我们的结果表明,有可能在人细胞的重编程中同时用替代的谱系特异性因子替代 OCT4 和 SOX2。在更广泛的层面上,它们还支持这样一种模型,即对抗谱系特异性网络是诱导多能性的基础。